The incidence of venous thromboembolism in patients with overt hyperthyroidism: A retrospective multicentre cohort study

Thrombosis and Haemostasis

Volumn 107, Issue 3, 2012, Pages 417-422

  Kootte, Ruud S ^a,b   Stuijver, Danka J F ^a,b   Dekkers, Olaf M ^c   van Zaane, Bregje ^a,b   Fliers, Eric ^b   Cannegieter, Suzanne C ^c   Gerdes, Victor E A ^a,b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Epidemiology; Hyperthyroidism; Risk factor; Venous thromboembolism

Indexed keywords

ACENOCOUMAROL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; THYROTROPIN; THYROXINE; WARFARIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FEMALE; HUMAN; HYPERTHYROIDISM; INCIDENCE; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; PHLEBOGRAPHY; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; RISK; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84857709745     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-10-0691     Document Type: Article

References (23)

1. Cushman M, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19-25.
2. Naess IA, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5: 692-699.
3. Heit JA, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-815.
4. Isma N, et al. Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmo Thrombophilia Study (MATS). Thromb Res 2009; 124: 663-666.
5. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program 2005; 1-12.
6. Debeij J, et al. The effect of changes in thyroxine and thyroid-stimulating hormone levels on the coagulation system. J Thromb Haemost 2010; 8: 2823-2826.
7. Erem C, et al. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 2002; 25: 345-350.
8. Homoncik M, et al. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 2007; 92: 3006-3012.
9. Marongiu F, et al. Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 1988; 11: 723-725.
10. Rogers JS, et al. Factor VIII activity and thyroid function. Ann Intern Med 1982; 97: 713-716.
11. Lippi G, et al. Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients. J Thromb Thrombolysis 2009; 28: 362-365.
12. Van Zaane B, et al. Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood 2010; 115: 4344-4349.
13. Danescu LG, et al. Venous thromboembolism in patients hospitalized with thyroid dysfunction. Clin Appl Thromb Hemost 2009; 15: 676-680.
14. Lin HC, et al. Increased risk of pulmonary embolism among patients with hyperthyroidism: a 5-year follow-up study. J Thromb Haemost 2010; 8: 2176-2181.
15. Anderson FA, Jr., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938.
16. Ho WK, et al. The incidence of venous thromboembolism: a prospective, community-based study in Perth, Western Australia. Med J Aust 2008; 189: 144-147.
17. Nordstrom M, et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232: 155-1560.
18. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-660.
19. Silverstein MD, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593.
20. Dagenais P, et al. A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J Rheumatol 1992; 19: 1393-1396.
21. Hofbauer LC, et al. Graves' disease associated with the primary antiphospholipid syndrome. J Rheumatol 1996; 23: 1435-1437.
22. Khochtali I, et al. Graves' disease associated with cerebrovascular disease and antiphospholipid antibody syndrome. Int J Endocrinol 2010; epub ahead of print.
23. Nabriski D, et al. Autoimmune thyroid disease and antiphospholipid antibodies. Am J Hematol 2000; 64: 73-75.